Literature DB >> 10504731

Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements.

M Ferrer1, T M Kapoor, T Strassmaier, W Weissenhorn, J J Skehel, D Oprian, S L Schreiber, D C Wiley, S C Harrison.   

Abstract

The trimeric, alpha-helical coiled-coil core of the HIV-1 gp41 ectodomain is thought to be part of a transient, receptor-triggered intermediate in the refolding of the envelope glycoprotein into a fusion-active conformation. In an effort to discover small organic inhibitors that block gp41 activation, we have generated a biased combinatorial chemical library of non-natural binding elements targeted to the gp41 core. From this library of 61,275 potential ligands, we have identified elements that, when covalently attached to a peptide derived from the gp41 outer-layer alpha-helix, contribute to the formation of a stable complex with the inner core and to inhibition of gp41-mediated cell fusion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10504731     DOI: 10.1038/13324

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  55 in total

1.  The core of the respiratory syncytial virus fusion protein is a trimeric coiled coil.

Authors:  J M Matthews; T F Young; S P Tucker; J P Mackay
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Mechanisms for HIV-1 Entry: Current Strategies to Interfere with This Step.

Authors:  Georgia D. Tomaras; Michael L. Greenberg
Journal:  Curr Infect Dis Rep       Date:  2001-02       Impact factor: 3.725

3.  The trimer-of-hairpins motif in membrane fusion: Visna virus.

Authors:  V N Malashkevich; M Singh; P S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

4.  Short constrained peptides that inhibit HIV-1 entry.

Authors:  Samuel K Sia; Peter A Carr; Andrea G Cochran; Vladimir N Malashkevich; Peter S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-04       Impact factor: 11.205

5.  Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion.

Authors:  T Suárez; W R Gallaher; A Agirre; F M Goñi; J L Nieva
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

6.  Targeting a binding pocket within the trimer-of-hairpins: small-molecule inhibition of viral fusion.

Authors:  Christopher Cianci; David R Langley; Douglas D Dischino; Yaxiong Sun; Kuo-Long Yu; Anne Stanley; Julia Roach; Zhufang Li; Richard Dalterio; Richard Colonno; Nicholas A Meanwell; Mark Krystal
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-06       Impact factor: 11.205

7.  Design of a potent D-peptide HIV-1 entry inhibitor with a strong barrier to resistance.

Authors:  Brett D Welch; J Nicholas Francis; Joseph S Redman; Suparna Paul; Matthew T Weinstock; Jacqueline D Reeves; Yolanda S Lie; Frank G Whitby; Debra M Eckert; Christopher P Hill; Michael J Root; Michael S Kay
Journal:  J Virol       Date:  2010-08-18       Impact factor: 5.103

8.  Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolates.

Authors:  Elisabetta Bianchi; Joseph G Joyce; Michael D Miller; Adam C Finnefrock; Xiaoping Liang; Marco Finotto; Paolo Ingallinella; Philip McKenna; Michael Citron; Elizabeth Ottinger; Robert W Hepler; Renee Hrin; Deborah Nahas; Chengwei Wu; David Montefiori; John W Shiver; Antonello Pessi; Peter S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-18       Impact factor: 11.205

9.  Structural and functional analysis of interhelical interactions in the human immunodeficiency virus type 1 gp41 envelope glycoprotein by alanine-scanning mutagenesis.

Authors:  M Lu; M O Stoller; S Wang; J Liu; M B Fagan; J H Nunberg
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

10.  Mutations of Epstein-Barr virus gH that are differentially able to support fusion with B cells or epithelial cells.

Authors:  Liguo Wu; Corina M Borza; Lindsey M Hutt-Fletcher
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.